These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6161416)

  • 1. Sickle cell (II): many agents near trials.
    Maugh TH
    Science; 1981 Jan; 211(4481):468-70. PubMed ID: 6161416
    [No Abstract]   [Full Text] [Related]  

  • 2. Sickle hemoglobin oxygen affinity-shifting strategies have unequal cerebrovascular risks.
    Hebbel RP; Hedlund BE
    Am J Hematol; 2018 Mar; 93(3):321-325. PubMed ID: 29150874
    [No Abstract]   [Full Text] [Related]  

  • 3. Understanding antisickling agents and the sickling process.
    Godwin M; Baysinger M
    Nurs Clin North Am; 1983 Mar; 18(1):207-14. PubMed ID: 6550864
    [No Abstract]   [Full Text] [Related]  

  • 4. Membrane modifiers in sickle cell disease.
    Benjamin LJ
    Ann N Y Acad Sci; 1989; 565():247-61. PubMed ID: 2672964
    [No Abstract]   [Full Text] [Related]  

  • 5. The biophysics of sickle cell hydroxyurea therapy.
    Eaton WA; Hofrichter J
    Science; 1995 May; 268(5214):1142-3. PubMed ID: 7539154
    [No Abstract]   [Full Text] [Related]  

  • 6. Polymerization of hemoglobin in sickle trait erythrocytes and lysates.
    Noguchi CT; Torchia DA; Schechter AN
    J Biol Chem; 1981 May; 256(9):4168-71. PubMed ID: 7217076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiologically based drug treatment of sickle cell disease.
    Steinberg MH
    Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of sickle hemoglobin polymerization and membrane properties on deformability of sickle erythrocytes in the microcirculation.
    Dong C; Chadwick RS; Schechter AN
    Biophys J; 1992 Sep; 63(3):774-83. PubMed ID: 1420913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea and erythropoietin therapy in sickle cell anemia.
    Goldberg MA; Brugnara C; Dover GJ; Schapira L; Lacroix L; Bunn HF
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):74-81. PubMed ID: 1379376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle hemoglobin polymerization in solution and in cells.
    Noguchi CT; Schechter AN
    Annu Rev Biophys Biophys Chem; 1985; 14():239-63. PubMed ID: 3890882
    [No Abstract]   [Full Text] [Related]  

  • 11. Developing treatment for sickle cell disease.
    Steinberg MH; Brugnara C
    Expert Opin Investig Drugs; 2002 May; 11(5):645-59. PubMed ID: 11996646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A temperature-dependent latent-period in the aggregation of sickle-cell deoxyhemoglobin.
    Malfa R; Steinhardt J
    Biochem Biophys Res Commun; 1974 Aug; 59(3):887-93. PubMed ID: 4411783
    [No Abstract]   [Full Text] [Related]  

  • 13. Membrane and endoskeletal defects in HbSS erythrocytes.
    Wallach DF
    Prog Clin Biol Res; 1981; 51():333-53. PubMed ID: 7022474
    [No Abstract]   [Full Text] [Related]  

  • 14. New antisickling agents.
    Labie D
    Haematologia (Budap); 1983; 16(1-4):105-8. PubMed ID: 6679483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity.
    Gladwin MT; Schechter AN; Shelhamer JH; Pannell LK; Conway DA; Hrinczenko BW; Nichols JS; Pease-Fye ME; Noguchi CT; Rodgers GP; Ognibene FP
    J Clin Invest; 1999 Oct; 104(7):937-45. PubMed ID: 10510334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
    Noguchi CT; Rodgers GP; Schechter AN
    Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro exposure to hydroxyurea reduces sickle red blood cell deformability.
    Huang Z; Louderback JG; King SB; Ballas SK; Kim-Shapiro DB
    Am J Hematol; 2001 Jul; 67(3):151-6. PubMed ID: 11391710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysteresis-like behavior of oxygen association-dissociation equilibrium curves of sickle cells determined by a new method.
    Mizukami H; Beaudoin AG; Bartnicki DE; Adams B
    Proc Soc Exp Biol Med; 1977 Feb; 154(2):304-9. PubMed ID: 14337
    [No Abstract]   [Full Text] [Related]  

  • 19. Denatured hemoglobin in sickle erythrocytes.
    Asakura T; Minakata K; Adachi K; Russell MO; Schwartz E
    J Clin Invest; 1977 Apr; 59(4):633-40. PubMed ID: 845254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
    Ueda Y; Bookchin RM
    J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.